Download as PDF
2018-CHEN-68027
Methicillin-resistant Staphylococcus aureus (MRSA) is a staph infection resistant to many antibiotics used to treat typical staph infections. According to Mayo Clinic Staff, there are two common types of MRSA: healthcare-associated MRSA (HA-MRSA) and community-associated MRSA (CA-MRSA). HA-MRSA tends to be the result of invasive procedures, e.g. device implantation. The latter, CA-MRSA, is spread through skin-to-skin contact, typically beginning as a painful boil. In addition, MRSA is considered to be even more life-threatening if combined with sepsis or necrotizing pneumonia. Because MRSA is drug-resistant, there is need for a method of prevention and elimination of the infection.

Researchers at Purdue University have developed a drug-free approach to eliminating MRSA. Using blue-light bleaching, along with hydrogen peroxide, have shown to eliminate a MRSA culture and a MRSA infection of a mouse wound. This has shown to be a safe and effective method of eliminating MRSA.

Advantages:
-Safe
-Effective
-Drug-free approach

Potential Applications:
-MRSA prevention
-MRSA treatment
Sep 24, 2019
CIP-Patent
United States
(None)
(None)

Sep 24, 2018
Utility Patent
United States
(None)
(None)

Sep 22, 2017
Provisional-Patent
United States
(None)
(None)
Purdue Office of Technology Commercialization
The Convergence Center
101 Foundry Drive, Suite 2500
West Lafayette, IN 47906

Phone: (765) 588-3475
Fax: (765) 463-3486
Email: otcip@prf.org